
The MyoMobile study will explore the UMANA T1 Heart Monitor, a novel real-time remote cardiac monitoring device. MyoMobile is a prospective, randomized study investigating the effect of a personalized mobile health intervention on the physical activity levels in patients with heart failure
Latest news
Investor
03.04.2025
Gpi to meet investors
On April 8 at the Mid & Small in London; on April 10 at the Appuntamento alle Colonne
Investor
28.03.2025
Presentation of the FY24 Results
Video webacast, Tuesday 1st April 2025 – 15:00 CET
Investor
28.03.2025
Full Year 2024: Double-Digit Growth
Revenue € 510 M, EBITDA € 105 M